Application 021165

Type
NDA
Sponsor
MERCK SHARP DOHME

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CLARINEXDESLORATADINETABLET;ORAL5MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0085-1264ClarinexDesloratadineMerck Sharp & Dohme Corp.NDACurrent
0085-1264ClarinexDesloratadineMerck Sharp & Dohme Corp.NDACurrent
0085-1264ClarinexDesloratadineMerck Sharp & Dohme Corp.NDACurrent
0085-1264ClarinexDesloratadineMerck Sharp & Dohme Corp.NDACurrent
0085-1264ClarinexDesloratadineMerck Sharp & Dohme Corp.NDACurrent
50090-0765ClarinexDesloratadineA-S Medication SolutionsNDACurrent
78206-119ClarinexDesloratadineOrganon LLCNDACurrent
78206-119ClarinexDesloratadineOrganon LLCNDACurrent
78206-119ClarinexDesloratadineOrganon LLCNDACurrent
78206-119ClarinexDesloratadineOrganon LLCNDACurrent
78206-188ClarinexDesloratadineOrganon LLCNDACurrent
78206-188ClarinexDesloratadineOrganon LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
58217SUPPL2019-04-04
58013SUPPL2019-03-18
57897SUPPL2019-03-05
57885SUPPL2019-03-04
36253SUPPL2014-04-25
4517SUPPL2014-04-24
14542SUPPL2012-05-03
4516SUPPL2010-12-28
26953SUPPL2006-12-28
4515SUPPL2006-12-28
4514SUPPL2006-12-28
36252SUPPL2004-06-01
4513SUPPL2004-02-03
41998SUPPL2003-07-08
26952SUPPL2002-02-08
41997ORIG2001-12-21
26951ORIG2001-12-21
14541ORIG2001-12-21